CLEW

Company Overview

Snapshot

Founded in December 2014 by Gal Salomon and Avigdor Faians, CLEW operates with 11–50 employees. The company has raised $20.5 million across 6 funding rounds from 5 investors. In June 2024, CLEW Medical partnered with AvaSure to enhance high-acuity care through AI-driven virtual surveillance.

Business overview

CLEW specializes in developing patient-level physiological predictive models using artificial intelligence and data science. Initially proven in intensive care units (ICUs), their technology is expanding to all care settings to assist healthcare providers in forecasting patient states. The company's solutions, including TeleICU and CLEWICU, are designed to improve clinical decision-making, patient outcomes, and safety, while also streamlining care and reducing costs. CLEW operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers in markets such as the United States, Europe, and Israel.

Strategic signal

In April 2024, CLEW expanded its intelligent clinical surveillance platform to cover all inpatient settings. This strategic move signifies the company's ambition to broaden its impact beyond critical care, offering a more comprehensive solution for hospitals and healthcare systems. For investors, this expansion indicates a significant growth opportunity and a stronger competitive position in the broader healthcare technology market, moving towards more pervasive patient monitoring and predictive analytics.

Company Intelligence Q&A

What is CLEW's core technology?

CLEW utilizes artificial intelligence and data science to develop patient-level physiological predictive models, initially for intensive care units and now expanding to all care settings.

When did CLEW receive FDA clearance for its AI-based predictive analytics?

CLEW Medical received FDA clearance for its AI-based predictive analytics technology to support adult ICU patient assessment in February 2021.

What was a significant recent partnership for CLEW?

In June 2024, AvaSure teamed up with CLEW Medical to boost high-acuity care with AI-driven virtual surveillance, indicating a strategic collaboration to enhance critical care capabilities.

What was a recent product launch by CLEW?

In March 2025, CLEW announced the launch of its Sepsis Virtual Unit (SVU), designed to enhance SEP-1 compliance and improve patient outcomes.

Who was recently appointed as CLEW's CEO?

In November 2022, CLEW announced the appointment of Paul Roscoe as its new CEO.